710 Differences in the susceptibility of human small cell lung cancer variants to NK cell-mediated lysis can be overcome with the addition of N803 (IL-15 superagonist)

Subjects

Subjects :

Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Details

Language :

English

ISSN :

20511426

Volume :

9

Issue :

Suppl 2

Database :

Directory of Open Access Journals

Journal :

Journal for ImmunoTherapy of Cancer

Publication Type :

Academic Journal

Accession number :

edsdoj.ff9fad5ed19743a08afce3907419db1d

Document Type :

article

Full Text :

https://doi.org/10.1136/jitc-2021-SITC2021.710